Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults.

Kizer JR, Benkeser D, Arnold AM, Djousse L, Zieman SJ, Mukamal KJ, Tracy RP, Mantzoros CS, Siscovick DS, Gottdiener JS, Ix JH.

J Clin Endocrinol Metab. 2013 Jan;98(1):255-63. doi: 10.1210/jc.2012-2103. Epub 2012 Nov 16.

2.

Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels.

Saito I, Yamagishi K, Chei CL, Cui R, Ohira T, Kitamura A, Kiyama M, Imano H, Okada T, Kato T, Hitsumoto S, Ishikawa Y, Tanigawa T, Iso H.

Atherosclerosis. 2013 Jul;229(1):222-7. doi: 10.1016/j.atherosclerosis.2013.04.014. Epub 2013 Apr 27.

PMID:
23676254
3.

High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study.

Sattar N, Watt P, Cherry L, Ebrahim S, Davey Smith G, Lawlor DA.

J Clin Endocrinol Metab. 2008 May;93(5):1846-9. doi: 10.1210/jc.2007-2603. Epub 2008 Feb 26.

PMID:
18303082
4.

High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study.

Ogorodnikova AD, Wassertheil-Smoller S, Mancuso P, Sowers MR, Rajpathak SN, Allison MA, Baird AE, Rodriguez B, Wildman RP.

Stroke. 2010 Jul;41(7):1376-81. doi: 10.1161/STROKEAHA.109.576546. Epub 2010 May 27.

5.

Total and high-molecular-weight adiponectin and risk of incident diabetes in older people.

Kizer JR, Arnold AM, Benkeser D, Ix JH, Djousse L, Zieman SJ, Barzilay JI, Tracy RP, Mantzoros CS, Siscovick DS, Mukamal KJ.

Diabetes Care. 2012 Feb;35(2):415-23. doi: 10.2337/dc11-1519. Epub 2011 Dec 6.

6.

Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study.

Kizer JR, Benkeser D, Arnold AM, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, Mantzoros CS, Defilippi CR, Newman AB, Djousse L.

Circulation. 2012 Dec 18;126(25):2951-61. doi: 10.1161/CIRCULATIONAHA.112.135202. Epub 2012 Nov 16.

7.

Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.

Macheret F, Bartz TM, Djousse L, Ix JH, Mukamal KJ, Zieman SJ, Siscovick DS, Tracy RP, Heckbert SR, Psaty BM, Kizer JR.

Heart. 2015 Sep;101(17):1368-74. doi: 10.1136/heartjnl-2014-307015. Epub 2015 Apr 8.

8.

Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study).

Karas MG, Benkeser D, Arnold AM, Bartz TM, Djousse L, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, Mantzoros CS, Gottdiener JS, deFilippi CR, Kizer JR.

Am J Cardiol. 2014 Jan 15;113(2):328-34. doi: 10.1016/j.amjcard.2013.09.027. Epub 2013 Oct 3.

9.

Adiponectin and risk of stroke: prospective study and meta-analysis.

Arregui M, Buijsse B, Fritsche A, di Giuseppe R, Schulze MB, Westphal S, Isermann B, Boeing H, Weikert C.

Stroke. 2014 Jan;45(1):10-7. doi: 10.1161/STROKEAHA.113.001851. Epub 2013 Nov 7.

10.

Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.

Liu G, Ding M, Chiuve SE, Rimm EB, Franks PW, Meigs JB, Hu FB, Sun Q.

Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2259-2267. Epub 2016 Sep 8.

11.

Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women.

Pischon T, Hu FB, Girman CJ, Rifai N, Manson JE, Rexrode KM, Rimm EB.

Atherosclerosis. 2011 Nov;219(1):322-9. doi: 10.1016/j.atherosclerosis.2011.07.011. Epub 2011 Jul 20.

12.

Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta-analysis of 17 case-control studies.

Zhang BC, Liu WJ, Che WL, Xu YW.

Clin Endocrinol (Oxf). 2012 Sep;77(3):370-8. doi: 10.1111/j.1365-2265.2011.04260.x.

PMID:
21995850
13.

Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.

Kizer JR, Benkeser D, Arnold AM, Ix JH, Mukamal KJ, Djousse L, Tracy RP, Siscovick DS, Psaty BM, Zieman SJ.

Atherosclerosis. 2014 Jul;235(1):116-21. doi: 10.1016/j.atherosclerosis.2014.04.013. Epub 2014 Apr 30.

14.

Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.

Agarwal I, Glazer NL, Barasch E, Biggs ML, Djousse L, Fitzpatrick AL, Gottdiener JS, Ix JH, Kizer JR, Rimm EB, Sicovick DS, Tracy RP, Mukamal KJ.

Circ Arrhythm Electrophysiol. 2014 Aug;7(4):583-9. doi: 10.1161/CIRCEP.114.001610. Epub 2014 Jun 24.

15.

High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.

Krzyzanowska K, Aso Y, Mittermayer F, Inukai T, Brix J, Schernthaner G.

Transl Res. 2009 Apr;153(4):199-203. doi: 10.1016/j.trsl.2009.01.009. Epub 2009 Feb 28.

PMID:
19304279
16.

High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men.

von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, Nawroth PP, Bierhaus A, Dugi KA.

Atherosclerosis. 2008 Jul;199(1):123-8. Epub 2007 Nov 19.

PMID:
18021784
17.

High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation.

Ho DY, Cook NR, Britton KA, Kim E, Creager MA, Ridker PM, Pradhan AD.

Circulation. 2011 Nov 22;124(21):2303-11. doi: 10.1161/CIRCULATIONAHA.111.045187. Epub 2011 Oct 24.

18.

Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients.

Wang W, Xing W, Zhang H, Ding M, Shang L, Lau WB, Wang X, Li R.

Clin Endocrinol (Oxf). 2013 Apr;78(4):539-44. doi: 10.1111/j.1365-2265.2012.04444.x.

PMID:
22612653
19.

Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts.

Saber H, Yakoob MY, Shi P, Longstreth WT Jr, Lemaitre RN, Siscovick D, Rexrode KM, Willett WC, Mozaffarian D.

Stroke. 2017 Oct;48(10):2678-2685. doi: 10.1161/STROKEAHA.117.018235. Epub 2017 Aug 22.

PMID:
28830976
20.

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease.

von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D.

Eur Heart J. 2008 May;29(10):1307-15. doi: 10.1093/eurheartj/ehn135. Epub 2008 Apr 5.

PMID:
18390868

Supplemental Content

Support Center